搜尋
Erasca Inc
ERAS添加自選
13.670USD
-0.310-2.22%
收盤 06/18, 16:00（美東）報價延遲15分鐘
4.25B總市值
虧損本益比TTM
股東統計
更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
Frazier Life Sciences Management, L.P.
7.31%
Lim (Jonathan E)
6.26%
VR Adviser, LLC
5.74%
T. Rowe Price Investment Management, Inc.
5.18%
Paradigm BioCapital Advisors LP
4.87%
其他
70.64%
持股股東
持股股東
佔比
Frazier Life Sciences Management, L.P.
7.31%
Lim (Jonathan E)
6.26%
VR Adviser, LLC
5.74%
T. Rowe Price Investment Management, Inc.
5.18%
Paradigm BioCapital Advisors LP
4.87%
其他
70.64%
股東類型
持股股東
佔比
Investment Advisor
26.84%
Venture Capital
19.41%
Hedge Fund
15.49%
Private Equity
7.31%
Individual Investor
6.70%
Investment Advisor/Hedge Fund
6.57%
Corporation
3.96%
Research Firm
1.94%
Bank and Trust
0.24%
其他
11.56%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
333
240.06M
77.62%
-10.46M
2025Q4
302
232.29M
89.71%
--
2025Q3
310
232.29M
93.65%
-60.69K
2025Q2
313
232.41M
93.79%
-6.69M
2025Q1
306
239.26M
97.34%
-36.46M
2024Q4
312
245.09M
99.26%
-1.10M
2024Q3
302
246.05M
87.29%
+28.86M
2024Q2
292
216.94M
64.16%
+84.80M
2024Q1
269
85.99M
67.39%
-16.11M
2023Q4
259
82.61M
63.62%
+857.42K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Frazier Life Sciences Management, L.P.
22.73M
7.31%
--
--
Dec 31, 2025
Lim (Jonathan E)
19.46M
6.26%
--
--
Apr 15, 2025
VR Adviser, LLC
17.86M
5.75%
--
--
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
16.11M
5.18%
-4.12M
-20.37%
Dec 31, 2025
Paradigm BioCapital Advisors LP
15.16M
4.88%
+1.00M
+7.06%
Jan 07, 2026
Suvretta Capital Management, LLC
14.50M
4.67%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
13.50M
4.34%
+370.90K
+2.83%
Dec 31, 2025
Logos Global Management LP
13.00M
4.18%
-2.15M
-14.19%
Dec 31, 2025
City Hill Ventures, LLC
12.90M
4.15%
--
--
Sep 30, 2024
Novartis Pharma AG
12.31M
3.96%
--
--
Dec 31, 2024
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Virtus LifeSci Biotech Clinical Trials ETF
1.07%
ALPS Medical Breakthroughs ETF
0.28%
ProShares Ultra Nasdaq Biotechnology
0.11%
iShares Micro-Cap ETF
0.08%
Invesco Nasdaq Biotechnology ETF
0.07%
Fidelity Enhanced Small Cap ETF
0.05%
iShares Russell 2000 Value ETF
0.04%
iShares Biotechnology ETF
0.03%
ProShares UltraPro Russell2000
0.02%
iShares US Small-Cap Equity Factor ETF
0.02%
查看更多
Virtus LifeSci Biotech Clinical Trials ETF
佔比1.07%
ALPS Medical Breakthroughs ETF
佔比0.28%
ProShares Ultra Nasdaq Biotechnology
佔比0.11%
iShares Micro-Cap ETF
佔比0.08%
Invesco Nasdaq Biotechnology ETF
佔比0.07%
Fidelity Enhanced Small Cap ETF
佔比0.05%
iShares Russell 2000 Value ETF
佔比0.04%
iShares Biotechnology ETF
佔比0.03%
ProShares UltraPro Russell2000
佔比0.02%
iShares US Small-Cap Equity Factor ETF
佔比0.02%
